Institutional members access full text with Ovid®

Share this article on:


French, Jacqueline

CONTINUUM: Lifelong Learning in Neurology: August 2007 - Volume 13 - Issue 4, Epilepsy - p 71-90
doi: 10.1212/01.CON.0000284535.50896.29

Many effective antiepileptic drugs (AEDs) are currently available. These are generally subdivided into the first-generation AEDs (phenytoin, carbamazepine, phenobarbital, primidone, valproate, ethosuximide, and the benzodiazepines), and the second-generation AEDs (felbamate, gabapentin, lamotrigine, topiramate, tiagabine, oxcarbazepine, levetiracetam, zonisamide, and pregabalin). Selection of the ideal drug for each individual patient should be based on a number of factors, including cost, spectrum of activity, potential for dose-related and serious side effects, drug interactions, and others. Special consideration must be given to populations such as women, older adults, and newly diagnosed patients. When all factors are taken into consideration, most patients can find an effective and well-tolerated drug.

© 2007 American Academy of Neurology
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website